A new immunosuppressive agent makes its debut in primate models of kidney transplantation. The drug has the potential to join the ranks of immunosuppressants currently used in transplantation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kung, L. et al. Am. J. Transplant. 1, 325–333 (2001).
Changelian, P.S. et al. Science 302, 875–878 (2003).
O'Shea, J.J. Immunity 7, 1–11 (1997).
Leonard, W.J. Annu. Rev. Med. 47, 229–239 (1996).
Spitzer, T.R. et al. Transplantation 68, 480–484 (1999).
Lakkis, F.G. & Dai, Z. Curr. Opin. Immunol. 11, 504–508 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sykes, M. JAKing up immunosuppression. Nat Med 9, 1458–1459 (2003). https://doi.org/10.1038/nm1203-1458
Issue Date:
DOI: https://doi.org/10.1038/nm1203-1458